• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ETS家族成员GABPα调节雄激素受体信号传导,并介导前列腺癌的侵袭性表型。

The ETS family member GABPα modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancer.

作者信息

Sharma Naomi L, Massie Charlie E, Butter Falk, Mann Matthias, Bon Helene, Ramos-Montoya Antonio, Menon Suraj, Stark Rory, Lamb Alastair D, Scott Helen E, Warren Anne Y, Neal David E, Mills Ian G

机构信息

Uro-oncology Research Group, CRUK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK Department of Urology, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, UK.

Uro-oncology Research Group, CRUK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.

出版信息

Nucleic Acids Res. 2014 Jun;42(10):6256-69. doi: 10.1093/nar/gku281. Epub 2014 Apr 21.

DOI:10.1093/nar/gku281
PMID:24753418
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4041454/
Abstract

In prostate cancer (PC), the androgen receptor (AR) is a key transcription factor at all disease stages, including the advanced stage of castrate-resistant prostate cancer (CRPC). In the present study, we show that GABPα, an ETS factor that is up-regulated in PC, is an AR-interacting transcription factor. Expression of GABPα enables PC cell lines to acquire some of the molecular and cellular characteristics of CRPC tissues as well as more aggressive growth phenotypes. GABPα has a transcriptional role that dissects the overlapping cistromes of the two most common ETS gene fusions in PC: overlapping significantly with ETV1 but not with ERG target genes. GABPα bound predominantly to gene promoters, regulated the expression of one-third of AR target genes and modulated sensitivity to AR antagonists in hormone responsive and castrate resistant PC models. This study supports a critical role for GABPα in CRPC and reveals potential targets for therapeutic intervention.

摘要

在前列腺癌(PC)中,雄激素受体(AR)在所有疾病阶段都是关键转录因子,包括去势抵抗性前列腺癌(CRPC)的晚期阶段。在本研究中,我们发现GABPα(一种在PC中上调的ETS因子)是一种与AR相互作用的转录因子。GABPα的表达使PC细胞系能够获得CRPC组织的一些分子和细胞特征以及更具侵袭性的生长表型。GABPα具有转录作用,可剖析PC中两种最常见的ETS基因融合的重叠顺反子组:与ETV1显著重叠,但与ERG靶基因不重叠。GABPα主要与基因启动子结合,调节三分之一的AR靶基因的表达,并在激素反应性和去势抵抗性PC模型中调节对AR拮抗剂的敏感性。本研究支持GABPα在CRPC中的关键作用,并揭示了治疗干预的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0c7/4041454/099a61f7d025/gku281fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0c7/4041454/1f3c65e0a4e7/gku281fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0c7/4041454/4de7fe4afc50/gku281fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0c7/4041454/6f93d0cefd48/gku281fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0c7/4041454/099a61f7d025/gku281fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0c7/4041454/1f3c65e0a4e7/gku281fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0c7/4041454/4de7fe4afc50/gku281fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0c7/4041454/6f93d0cefd48/gku281fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0c7/4041454/099a61f7d025/gku281fig4.jpg

相似文献

1
The ETS family member GABPα modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancer.ETS家族成员GABPα调节雄激素受体信号传导,并介导前列腺癌的侵袭性表型。
Nucleic Acids Res. 2014 Jun;42(10):6256-69. doi: 10.1093/nar/gku281. Epub 2014 Apr 21.
2
Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles.驱动前列腺癌进展的雄激素受体依赖性和非依赖性机制:多视角治疗靶点的机遇
Oncotarget. 2017 Jan 10;8(2):3724-3745. doi: 10.18632/oncotarget.12554.
3
Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer.糖皮质激素受体活性有助于前列腺癌对雄激素靶向治疗的抵抗。
Horm Cancer. 2014 Apr;5(2):72-89. doi: 10.1007/s12672-014-0173-2. Epub 2014 Mar 11.
4
ELF3 is a repressor of androgen receptor action in prostate cancer cells.ELF3 是前列腺癌细胞中雄激素受体作用的抑制剂。
Oncogene. 2014 Feb 13;33(7):862-71. doi: 10.1038/onc.2013.15. Epub 2013 Feb 25.
5
TACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancer.TACC2是一种雄激素反应性细胞周期调节因子,可促进雄激素介导的前列腺癌生长及去势抵抗性生长。
Mol Endocrinol. 2012 May;26(5):748-61. doi: 10.1210/me.2011-1242. Epub 2012 Mar 28.
6
TALEN-engineered AR gene rearrangements reveal endocrine uncoupling of androgen receptor in prostate cancer.TALEN 技术构建的 AR 基因重排揭示前列腺癌中雄激素受体的内分泌分离。
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17492-7. doi: 10.1073/pnas.1308587110. Epub 2013 Oct 7.
7
Targeting Binding Function-3 of the Androgen Receptor Blocks Its Co-Chaperone Interactions, Nuclear Translocation, and Activation.靶向雄激素受体的结合功能-3可阻断其共伴侣相互作用、核转位及激活。
Mol Cancer Ther. 2016 Dec;15(12):2936-2945. doi: 10.1158/1535-7163.MCT-16-0354. Epub 2016 Oct 7.
8
Moving Towards Precision Urologic Oncology: Targeting Enzalutamide-resistant Prostate Cancer and Mutated Forms of the Androgen Receptor Using the Novel Inhibitor Darolutamide (ODM-201).迈向精准泌尿肿瘤学:利用新型抑制剂达罗他胺(ODM-201)靶向恩杂鲁胺耐药前列腺癌和雄激素受体突变体。
Eur Urol. 2018 Jan;73(1):4-8. doi: 10.1016/j.eururo.2017.08.012. Epub 2017 Aug 26.
9
Sintokamide A Is a Novel Antagonist of Androgen Receptor That Uniquely Binds Activation Function-1 in Its Amino-terminal Domain.辛托卡胺A是一种新型雄激素受体拮抗剂,它独特地结合其氨基末端结构域中的激活功能-1。
J Biol Chem. 2016 Oct 14;291(42):22231-22243. doi: 10.1074/jbc.M116.734475. Epub 2016 Aug 30.
10
Lupeol, a novel androgen receptor inhibitor: implications in prostate cancer therapy.羽扇豆醇,一种新型雄激素受体抑制剂:在前列腺癌治疗中的意义。
Clin Cancer Res. 2011 Aug 15;17(16):5379-91. doi: 10.1158/1078-0432.CCR-11-0916. Epub 2011 Jun 28.

引用本文的文献

1
SNP rs9364554 Modulates Androgen Receptor Binding and Drug Response in Prostate Cancer.单核苷酸多态性rs9364554调节前列腺癌中的雄激素受体结合及药物反应。
Biomolecules. 2025 Jan 4;15(1):64. doi: 10.3390/biom15010064.
2
GABPA inhibits tumorigenesis in clear cell renal cell carcinoma by regulating ferroptosis through ACSL4.GABPA 通过调节 ACSL4 抑制肾透明细胞癌中的铁死亡从而抑制肿瘤发生。
Sci Rep. 2024 Nov 3;14(1):26521. doi: 10.1038/s41598-024-78441-z.
3
Cis-Regulatory Element and Transcription Factor Circuitry Required for Cell-Type Specific Expression of FOXP3.

本文引用的文献

1
Concordant integrative gene set enrichment analysis of multiple large-scale two-sample expression data sets.多组大规模两样本表达数据集的一致整合基因集富集分析。
BMC Genomics. 2014;15 Suppl 1(Suppl 1):S6. doi: 10.1186/1471-2164-15-S1-S6. Epub 2014 Jan 24.
2
Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia.儿童急性淋巴细胞白血病的综合遗传和表观遗传学分析。
J Clin Invest. 2013 Jul;123(7):3099-111. doi: 10.1172/JCI66203. Epub 2013 Jun 10.
3
ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss.
FOXP3细胞类型特异性表达所需的顺式调控元件和转录因子调控网络
bioRxiv. 2025 Jan 14:2024.08.30.610436. doi: 10.1101/2024.08.30.610436.
4
Autocrine VEGF-B signaling maintains lipid synthesis and mitochondrial fitness to support T cell immune responses.自分泌 VEGF-B 信号维持脂质合成和线粒体功能,以支持 T 细胞免疫应答。
J Clin Invest. 2024 Aug 15;134(16):e176586. doi: 10.1172/JCI176586.
5
Intra-promoter switch of transcription initiation sites in proliferation signaling-dependent RNA metabolism.启动子内转录起始位点切换在增殖信号依赖性 RNA 代谢中。
Nat Struct Mol Biol. 2023 Dec;30(12):1970-1984. doi: 10.1038/s41594-023-01156-8. Epub 2023 Nov 23.
6
Extensive germline-somatic interplay contributes to prostate cancer progression through HNF1B co-option of TMPRSS2-ERG.广泛的种系-体细胞相互作用通过HNF1B对TMPRSS2-ERG的选择作用促进前列腺癌进展。
Nat Commun. 2022 Nov 28;13(1):7320. doi: 10.1038/s41467-022-34994-z.
7
Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones.前列腺原位肿瘤的时空分析表明存在治疗抵抗性克隆的预先存在。
Nat Commun. 2022 Sep 17;13(1):5475. doi: 10.1038/s41467-022-33069-3.
8
From Omics to Multi-Omics Approaches for In-Depth Analysis of the Molecular Mechanisms of Prostate Cancer.从组学到多组学方法深入分析前列腺癌的分子机制。
Int J Mol Sci. 2022 Jun 3;23(11):6281. doi: 10.3390/ijms23116281.
9
GABPA-activated TGFBR2 transcription inhibits aggressiveness but is epigenetically erased by oncometabolites in renal cell carcinoma.GABPA 激活的 TGFBR2 转录抑制侵袭性,但在肾细胞癌中被致癌代谢物通过表观遗传方式消除。
J Exp Clin Cancer Res. 2022 May 12;41(1):173. doi: 10.1186/s13046-022-02382-6.
10
Transcription factor network analysis based on single cell RNA-seq identifies that Trichostatin-a reverses docetaxel resistance in prostate Cancer.基于单细胞 RNA-seq 的转录因子网络分析表明,曲古抑菌素 A 可逆转前列腺癌对多西他赛的耐药性。
BMC Cancer. 2021 Dec 8;21(1):1316. doi: 10.1186/s12885-021-09048-0.
ETS 因子重编程雄激素受体染色质,并对 PTEN 缺失作出反应,引发前列腺肿瘤发生。
Nat Med. 2013 Aug;19(8):1023-9. doi: 10.1038/nm.3216. Epub 2013 Jun 30.
4
The Genomic HyperBrowser: an analysis web server for genome-scale data.基因组超浏览器:一个用于基因组规模数据的分析网络服务器。
Nucleic Acids Res. 2013 Jul;41(Web Server issue):W133-41. doi: 10.1093/nar/gkt342. Epub 2013 Apr 30.
5
ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients.ETV1 调控雄激素代谢并促进靶向小鼠和患者的侵袭性前列腺癌。
Genes Dev. 2013 Mar 15;27(6):683-98. doi: 10.1101/gad.211011.112.
6
The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man.雄激素受体在人类去势抵抗性前列腺癌中诱导了一个独特的转录程序。
Cancer Cell. 2013 Jan 14;23(1):35-47. doi: 10.1016/j.ccr.2012.11.010. Epub 2012 Dec 20.
7
An integrated encyclopedia of DNA elements in the human genome.人类基因组中 DNA 元件的综合百科全书。
Nature. 2012 Sep 6;489(7414):57-74. doi: 10.1038/nature11247.
8
Vitamin D receptor binding, chromatin states and association with multiple sclerosis.维生素 D 受体结合、染色质状态及其与多发性硬化症的关联。
Hum Mol Genet. 2012 Aug 15;21(16):3575-86. doi: 10.1093/hmg/dds189. Epub 2012 May 16.
9
The differential disease regulome.差异化疾病调控网络。
BMC Genomics. 2011 Jul 7;12:353. doi: 10.1186/1471-2164-12-353.
10
The role of chromatin accessibility in directing the widespread, overlapping patterns of Drosophila transcription factor binding.染色质可及性在指导果蝇转录因子结合的广泛重叠模式中的作用。
Genome Biol. 2011;12(4):R34. doi: 10.1186/gb-2011-12-4-r34. Epub 2011 Apr 7.